Darolutamide shows promise for treatment of prostate cancer
Orion’s and Bayer’s darolutamide has shown substantial efficacy in the treatment of prostate cancer.
Read More
Tag: ARAMIS
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
